Reference
·Supporting source
Korean Implant Brand ASP Versus Straumann/Nobel Biocare
~40-50% of premium brand ASP
Korean implant brands (Osstem, Dentium, Megagen) distribute in Thailand at approximately 40-50% of Straumann and Nobel Biocare average selling price. The pricing spread is the main lever compressing premium-clinic gross margin on implant body from approximately 62% to 55% as Korean unit share rises toward 35-40% of Thai implant volume by 2027.
Figure in context
Korean implant brands (Osstem, Dentium, Megagen) distribute in Thailand at approximately 40-50% of Straumann and Nobel Biocare average selling price. The pricing spread is the main lever compressing premium-clinic gross margin on implant body from approximately 62% to 55% as Korean unit share rises toward 35-40% of Thai implant volume by 2027.
Korean implant brands (Osstem, Dentium, Megagen) distribute in Thailand at approximately 40-50% of Straumann and Nobel Biocare average selling price. The pricing spread is the main lever compressing premium-clinic gross margin on implant body from approximately 62% to 55% as Korean unit share rises toward 35-40% of Thai implant volume by 2027.
Time scope
FY2024-2027E
Source basis
Supporting source
Interpretation notes
What this tells you
Korean implant brands (Osstem, Dentium, Megagen) distribute in Thailand at approximately 40-50% of Straumann and Nobel Biocare average selling price. The pricing spread is the main lever compressing premium-clinic gross margin on implant body from approximately 62% to 55% as Korean unit share rises toward 35-40% of Thai implant volume by 2027.
What not to do with it
Use the linked report for interpretation and keep basis differences explicit.
Related figures
Adjacent numbers that add context without drowning the value.
Thailand International Dental Tourism Visits (2027E)
Tourism Authority of Thailand, SCB EIC outlook, operator triangulation
Thailand Dental Tourism Average Ticket (2027E)
Operator pricing pages, Dentsu Thailand patient survey, SCB EIC
Premium Full-Arch Implant Share of Dental Tourism Revenue (2027E)
Operator disclosures, Dentsu patient behaviour survey, SCB EIC outlook
Digital Workflow Penetration in Premium Thai Dental Clinics (2027E)
3Shape A/S Digital Dentistry Adoption Report 2024, operator interviews, SCB EIC
Customer Acquisition Cost Reduction Via Cross-Border Telehealth
Dentsu Thailand Inbound Medical Tourism Patient Behaviour Survey 2024
BDMS Dental Cluster Premium Chair Capacity Target (End-2026)
BDMS FY2024 annual report, investor presentations
Report context
Atlas actors in this figure's reports
Profiles covered in the report that cite this number.